Drug maker Novartis AG (NOVN.CH) is in advanced talks to acquire MorphoSys AG (MOR.DE), two people familiar with the matter told Reuters on Monday.
The sources added that there is no certainty that negotiations on the deal will be successful and asked to remain anonymous as the matter is confidential. They declined to provide any information on the acquisition price.
MorphoSys shares are currently gaining nearly 37%.

Source: xStation
Three Markets to Watch Next Week (13.11.2026)
US Open: Wall Street tries to recover as Nvidia and Fed uncertainty weigh on sentiment
Economic Calendar: U.S. PPI inflation takes center stage. What will today's session bring❓
Morning Wrap - Will the markets recover from the scandal involving Nvidia's ousted CEO❓